Ocrevus, the new multiple sclerosis drug approved by the FDA, can be used against the most common form of MS - the relapsing-remitting type. It's also approved for primary progressive MS, a very aggressive form of the disease that affects 10 to 15 percent of MS patients. http://nbcnews.to/2nhGr5O | NBC Nightly News with Tom Llamas